Method of stimulating the motility of the gastrointestinal system using growth hormone secretagogues

Details for Australian Patent Application No. 2005272598 (hide)

Owner Helsinn Therapeutics (U.S.), Inc.

Inventors Polvino, Wiliam J.

Agent Wrays

Pub. Number AU-B-2005272598

PCT Pub. Number WO2006/020930

Priority 60/600,959 12.08.04 US

Filing date 12 August 2005

Wipo publication date 23 February 2006

Acceptance publication date 17 November 2011

International Classifications

A61K 38/05 (2006.01) Medicinal preparations containing peptides - Dipeptides

A61K 38/06 (2006.01) Medicinal preparations containing peptides - Tripeptides

A61K 38/07 (2006.01) Medicinal preparations containing peptides - Tetrapeptides

A61K 38/08 (2006.01) Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61K 38/25 (2006.01) Medicinal preparations containing peptides - Growth hormone-releasing factor (GH-RF) (Somatoliberin)

Event Publications

1 March 2007 PCT application entered the National Phase

  PCT publication WO2006/020930 Priority application(s): WO2006/020930

18 June 2009 Assignment before Grant

  Sapphire Therapeutics, Inc. The application has been assigned to Helsinn Therapeutics (U.S.), Inc.

17 November 2011 Application Accepted

  Published as AU-B-2005272598

15 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005272603-Stabilizing formulations

2005272597-Intragastric volume-occupying device